28.06.2019 • NewsDede WillamsNouryon

Nouryon Expands Dialkyl Peroxide in China

Nouryon Expands Dialkyl Peroxide in China (c) Nouryon
Nouryon Expands Dialkyl Peroxide in China (c) Nouryon

Nouryon, the former Akzo Nobel specialty chemicals business, has increased capacity for dialkyl peroxide by 25% at its Ningbo site in China. The product, sold under the name Perkadox 14, is a key ingredient in many elastomer-based products, ranging from sports goods to industrial wires and cables.

The company said demand for the peroxide is increasing in Asia and worldwide, not least because it has less odor than other organic peroxides on the market. This, Nouryon said, makes it ideal for consumer products such as athletic shoe soles and yoga mats.

Since 2018, Johan Landfors, managing director Polymer Chemistry said Nouryon has  invested more than €100 million to build organic peroxides production capacity across the globe and as a global leader will continue to invest in expansion.

 The Ningbo project is the latest in a series of investments the Dutch company has made recently to improve supply to polymer market customers in India, Mexico and the US.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.